Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Hydrocodone bitartrate 2.5 mg and paracetamol 325 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 5 mg and paracetamol 325 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 2.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 2.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 5 mg and paracetamol 500 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 10 mg and ibuprofen 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 2.5 mg and ibuprofen 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 7.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 2.5 mg and paracetamol 325 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 5 mg and paracetamol 500 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 5 mg and ibuprofen 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 7.5 mg and paracetamol 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 750 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 10 mg and paracetamol 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 2.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 7.5 mg and ibuprofen 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 5 mg and paracetamol 325 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 10 mg and paracetamol 660 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 5 mg and paracetamol 556 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 500 microgram/mL and paracetamol 21.7 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 500 microgram/mL and paracetamol 21.7 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 333 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 333 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 5 mg and paracetamol 500 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 7.5 mg and paracetamol 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 7.5 mg and ibuprofen 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 2.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 2.5 mg and paracetamol 325 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |